• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ventyx Biosciences Inc (NQ: VTYX )

    1.970 +0.010 (+0.51%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,231,695
    Open 1.980
    Bid (Size) 1.930 (80)
    Ask (Size) 1.960 (16)
    Prev. Close 1.960
    Today's Range 1.790 - 2.010
    52wk Range 1.790 - 38.20
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q2 2024
    VTYX stock results show that Ventyx Biosciences beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Dow Edges Lower; Ventyx Biosciences Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities

    Performance

    YTD
    -20.88%
    -20.88%
    1 Month
    -29.64%
    -29.64%
    3 Month
    -57.86%
    -57.86%
    6 Month
    -60.91%
    -60.91%
    1 Year
    -93.82%
    -93.82%

    More News

    Read More
    Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
    Via Benzinga
    Exposures Fossil Fuels
    Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further
    Via Benzinga
    S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    VTYX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – VTYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    VTYX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    VTYX DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.